Guardian Pharmacy Services (NYSE:GRDN) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen cut shares of Guardian Pharmacy Services (NYSE:GRDN) from a strong-buy rating to a buy rating in a research report report published on Friday.

A number of other equities research analysts have also recently weighed in on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Guardian Pharmacy Services in a report on Saturday, September 27th. Truist Financial raised their price target on Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a report on Friday, September 26th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $26.33.

Guardian Pharmacy Services Trading Down 2.1%

Shares of GRDN opened at $23.92 on Friday. Guardian Pharmacy Services has a 1 year low of $16.50 and a 1 year high of $30.39. The stock has a 50 day simple moving average of $25.02 and a 200-day simple moving average of $23.03. The stock has a market cap of $1.51 billion and a PE ratio of -15.73.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in GRDN. GAMMA Investing LLC bought a new position in shares of Guardian Pharmacy Services in the 1st quarter worth $170,000. Peregrine Capital Management LLC boosted its position in shares of Guardian Pharmacy Services by 56.1% in the 1st quarter. Peregrine Capital Management LLC now owns 176,539 shares of the company’s stock worth $3,753,000 after purchasing an additional 63,464 shares during the last quarter. Calamos Advisors LLC lifted its holdings in Guardian Pharmacy Services by 61.5% during the first quarter. Calamos Advisors LLC now owns 39,919 shares of the company’s stock worth $849,000 after acquiring an additional 15,194 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Guardian Pharmacy Services by 55.9% during the first quarter. Bank of New York Mellon Corp now owns 21,196 shares of the company’s stock worth $451,000 after acquiring an additional 7,597 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in Guardian Pharmacy Services by 0.6% during the first quarter. Brown Advisory Inc. now owns 1,602,824 shares of the company’s stock worth $34,076,000 after acquiring an additional 8,870 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.